UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)

PloS one, 2016-05, Vol.11 (5), p.e0154596-e0154596

2016

Volltextzugriff (PDF)

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years

JAMA neurology, 2019-02, Vol.76 (2), p.152

2019

Volltextzugriff (PDF)

The importance of understanding individual differences in Down syndrome [version 1; peer review: 2 approved]

F1000 research, 2016, Vol.5, p.389

2016

Volltextzugriff (PDF)

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

Journal of neurodevelopmental disorders, 2020-01, Vol.12 (1), p.4-4, Article 4

2020

Volltextzugriff (PDF)

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Journal of neurodevelopmental disorders, 2021-12, Vol.13 (1), p.1-48, Article 48

2021

Volltextzugriff (PDF)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

Alzheimer's & dementia, 2019-02, Vol.15 (2), p.245-257

2019

Volltextzugriff (PDF)

Variation in the X-linked EFHC2 gene is associated with social cognitive abilities in males

PloS one, 2015-06, Vol.10 (6), p.e0131604-e0131604

2015

Volltextzugriff (PDF)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease

Alzheimer's research & therapy, 2019-03, Vol.11 (1), p.26-26, Article 26

2019

Volltextzugriff (PDF)

Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome

Alzheimer's & dementia, 2021-04, Vol.17 (4), p.595-604

2021

Volltextzugriff (PDF)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

Alzheimer's research & therapy, 2018-04, Vol.10 (1), p.39-39, Article 39

2018

Volltextzugriff (PDF)

Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome

Alzheimer's & dementia, 2023-11, Vol.19 (11), p.5129-5137

2023

Volltextzugriff (PDF)

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy

Psychopharmacologia, 2011-05, Vol.215 (1), p.105-115

2011

Volltextzugriff (PDF)

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome

Wellcome open research, 2016-11, Vol.1, p.11-11

2016

Volltextzugriff (PDF)

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

Frontiers in psychology, 2019-01, Vol.9, p.2730-2730

2019

Volltextzugriff (PDF)

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

Frontiers in psychiatry, 2019-04, Vol.10, p.158-158

2019

Volltextzugriff (PDF)

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Annals of clinical and translational neurology, 2018-06, Vol.5 (6), p.741-751

2018

Volltextzugriff (PDF)

Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”

Alzheimer's & dementia, 2019-09, Vol.15 (9), p.1238-1239

2019

Volltextzugriff (PDF)

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome

JAMA network open, 2020-09, Vol.3 (9), p.e2018221-e2018221

2020

Volltextzugriff (PDF)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

Journal of neurodevelopmental disorders, 2019-08, Vol.11 (1), p.20-20, Article 20

2019

Volltextzugriff (PDF)

USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1076-P1077

2017

Volltextzugriff (PDF)

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome

Cerebral cortex (New York, N.Y. 1991), 2023-08, Vol.33 (16), p.9639-9651

2023

Volltextzugriff (PDF)

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome

Cerebral cortex (New York, N.Y. 1991), 2019-05, Vol.29 (5), p.2279-2290

2019

Volltextzugriff (PDF)

The mismatch negativity as an index of cognitive impairment in adults with Down syndrome

Alzheimer's & dementia, 2023-12, Vol.19 (S17), p.n/a

2023

Volltextzugriff (PDF)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

Molecular psychiatry, 2021-10, Vol.26 (10), p.5766-5788

2021

Volltextzugriff (PDF)

[P3–328]: USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

Alzheimer's & dementia, 2017-07, Vol.13 (7S_Part_22), p.P1076-P1077

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)
Buchkapitel
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS)

Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years

The importance of understanding individual differences in Down syndrome [version 1; peer review: 2 approved]

Health comorbidities and cognitive abilities across the lifespan in Down syndrome

Comparison of resting-state EEG between adults with Down syndrome and typically developing controls

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

Variation in the X-linked EFHC2 gene is associated with social cognitive abilities in males

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease

Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy

The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome

Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome

Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Reply to “Down Syndrome Cognitive Marker's Significance in Alzheimer's Disease and Dementia Management”

Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review

USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

The mismatch negativity as an index of cognitive abilities in adults with Down syndrome

Dynamic Causal Modeling of the Relationship between Cognition and Theta–alpha Oscillations in Adults with Down Syndrome

The mismatch negativity as an index of cognitive impairment in adults with Down syndrome

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

[P3–328]: USING FUNCTIONAL NEAR INFRARED SPECTROSCOPY (FNIRS) TO MEASURE FRONTAL CORTICAL ACTIVITY IN ADULTS WITH DOWN SYNDROME

Suchergebnisse filtern